Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms

International Journal of Pharmaceutics

Volumn 396, Issue 1-2, 2010, Pages 204-209

  Perrier, Thomas ^a   Saulnier, Patrick ^a   Fouchet, Florian ^a   Lautram, Nolwenn ^a   Benoît, Jean Pierre ^a  

^a UNIVERSITÉ D'ANGERS   (France)

Author keywords

Amphiphilic phospholipids; Electrokinetic measurements; Lipid NanoCapsules; Post insertion; Soft particle analysis

Indexed keywords

1,2 DISTEAROYL SN GLYCERO 3 PHOSPHOETHANOLAMINE N [METHOXY(POLYETHYLENE GLYCOL)]; AMPHOPHILE; LIPID; LIPID NANOCAPSULE; LIPOSOME; MACROGOL 2000; NANOCAPSULE; PHOSPHATIDYLETHANOLAMINE; SURFACTANT; UNCLASSIFIED DRUG; DRUG CARRIER; LABRAFAC WL 1349; MACROGOL DERIVATIVE; POLYETHYLENE GLYCOL-DISTEAROYLPHOSPHATIDYLETHANOLAMINE; SOLUTOL HS 15; STEARIC ACID DERIVATIVE; TRIACYLGLYCEROL;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; MICELLE; PARTICLE SIZE; PRIORITY JOURNAL; SALINITY; TEMPERATURE; ZETA POTENTIAL; CHEMICAL STRUCTURE; CHEMISTRY; GEL MOBILITY SHIFT ASSAY; MEDICINAL CHEMISTRY; NANOTECHNOLOGY; PHARMACEUTICS; PROCEDURES; TIME;

CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; ELECTROPHORETIC MOBILITY SHIFT ASSAY; LIPIDS; MOLECULAR STRUCTURE; NANOCAPSULES; NANOTECHNOLOGY; PARTICLE SIZE; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; STEARIC ACIDS; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE; TIME FACTORS; TRIGLYCERIDES;

EID: 77955056282     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.06.019     Document Type: Article

References (37)

1. Acharya S., Dilnawaz F., Sahoo S.K. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials 2009, 30:5737-5750.
2. Airaud C., Ibarboure E., Gaillard C., Héroguez V. Nanostructured polymer composite nanoparticles synthesized in a single step via simultaneous ROMP and ATRP under microemulsion conditions. J. Polym. Sci. Part A: Polym. Chem. 2009, 47:4014-4027.
3. Allen T.M., Sapra P., Moase E. Use of the post-insertion method for the formation of ligand-coupled liposomes. Cell. Mol. Biol. Lett. 2002, 7:217-219.
4. Anton N., Saulnier P., Béduneau A., Benoit J.-P. Salting-out effect induced by temperature cycling on a water/nonionic surfactant/oil system. J. Phys. Chem. B 2007, 111:3651-3657.
5. Byrne J.D., Betancourt T., Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Deliv. Rev. 2008, 60:1615-1626.
6. Fang C., Bhattarai N., Sun C., Zhang M. Functionalized nanoparticles with long-term stability in biological media. Small 2009, 5:1637-1641.
7. GRIFFIN W.C.J. Soc. Cosmet. Chem. 1949, 1:311.
8. GRIFFIN W.C.J. Soc. Cosmet. Chem. 1954, 5:4.
9. Griffin W.C.J. Kirk-Othmer Encyclopedia of Chemical Technology 1979, vol. 8. J. Wiley & Sons, New York, 900 and 620. 3rd ed.
10. Gupta A.K., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995-4021.
11. Hein C.D., Liu X.-M., Wang D. Click chemistry, a powerful tool for pharmaceutical sciences. Pharm. Res. 2008, 25:2216-2230.
12. Heurtault B., Saulnier P., Pech B., Proust J.E., Benoît J.P. Properties of polyethylene glycol 660 12-hydroxy stearate at a triglyceride/water interface. Int. J. Pharm. 2002, 242:167-170.
13. Heurtault B., Saulnier P., Pech B., Proust J.-E., Benoit J.-P. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm. Res. 2002, 19:875-880.
14. Heurtault B., Saulnier P., Pech B., Venier-Julienne M.-C., Proust J.-E., Phan-Tan-Luu R., Benoît J.-P. The influence of lipid nanocapsule composition on their size distribution. Eur. J. Pharm. Sci. 2003, 18:55-61.
15. Iden D.L., Allen T.M. In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach. Biochim. Biophys. Acta Biomembr. 2001, 1513:207-216.
16. Izquierdo P., Esquena J., Tadros Th.F., Dederen C., Garcia M.J., Azemar N., Solans C. Formation and stability of nano-emulsions prepared using the phase inversion temperature method. Langmuir 2002, 18:26-30.
17. Kim J.-Y., Kim J.-K., Park J.-S., Byun Y., Kim C.-K. The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator. Biomaterials 2009, 30:5751-5756.
18. Koenig S., Chechik V. Shell cross-linked Au nanoparicles. Langmuir 2006, 22:5168-5173.
19. Ljubimova J.Y., Fujita M., Ljubimov A.V., Torchilin V.P., Black K.L., Holler E. Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery. Nanomedicine 2008, 3:247-265.
20. Lutz J.-F., Zarafshani Z. Efficient construction of therapeutics, bioconjugates, biomaterials and bioactive surfaces using azide-alkyne " click" chemistry. Adv. Drug Deliv. Rev. 2008, 60:958-970.
21. Minkov I., Ivanova T., Panaiotov I., Proust J., Saulnier P. Reorganization of lipid nanocapsules at air-water interface: I. Kinetics of surface film formation. Colloids Surf. B 2005, 45:14-23.
22. Moreira J.N., Ishida T., Gaspar R., Allen T.M. Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity. Pharm. Res. 2002, 19:265-269.
23. Nasongkla N., Bey E., Ren J., Ai H., Khemtong C., Guthi J.S., Chin S.-F., Sherry A.D., Boothman D.A., Gao J. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 2006, 6:2427-2430.
24. Ohshima H. Electrophoretic mobility of soft particles. J. Colloid Interf. Sci. 1994, 163:474-483.
25. Ohshima H. Electrophoresis of soft particles. Adv. Colloid Interface Sci. 1995, 62:189-235.
26. Ohshima H. Electrokinetics of soft particles. Colloid Polym. Sci. 2007, 285:1411-1421.
27. Pellegrino T., Kudera S., Liedl T., Javier A.M., Manna L., Parak W.J. On the development of colloidal nanoparticles towards multifunctional structures and their possible use for biological applications. Small 2005, 1:48-63.
28. Sezgin Z., Yüksel N., Baykara T. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur. J. Pharm. Biopharm. 2006, 64:261-268.
29. Shi M., Ho K., Keating A., Shoichet M.S. Doxorubicin-conjugated immuno-nanoparticles for intracellular anticancer drug delivery. Adv. Funct. Mater. 2009, 19:1689-1696.
30. Sirion U., Yu J.B., Byoung S.L., Dae Y.C. Ionic polymer supported copper(I): a reusable catalyst for Huisgen's 1,3-dipolar cycloaddition. Synlett 2008, 2326-2330.
31. Taylor P. Ostwald ripening in emulsions. Adv. Colloid Interf. Sci. 1998, 75:107-163.
32. Vonarbourg A., Saulnier P., Passirani C., Benoit J.-P. Electrokinetic properties of noncharged lipid nanocapsules: influence of the dipolar distribution at the interface. Electrophoresis 2005, 26:2066-2075.
33. Vonarbourg A., Passirani C., Saulnier P., Benoit J.-P. Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. Biomaterials 2006, 27:4356-4373.
34. Vonarbourg A., Passirani C., Saulnier P., Simard P., Leroux J.C., Benoit J.P. Parameters influencing the stealthiness of colloidal drug delivery systems. J. Biomed. Mater. Res. Part A 2006, 78:620.
35. Yang T., Choi M.-K., Cui F.-D., Kim J.S., Chung S.-J., Shim C.-K., Kim D.-D. Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. J. Control. Release 2007, 120:169-177.
36. Zalipsky S. Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes. Bioconjugate Chem. 1993, 4:296-299.
37. Zhu J., Kell A.J., Workentin M.S. A retro-Diels-Alder reaction to uncover maleimide-modified surfaces on monolayer-protected nanoparticles for reversible covalent assembly. Org. Lett. 2006, 8:4993-4996.